Healthcare News and Research

Latest Healthcare News and Research

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

In a recent research article published in the journal of Science Immunology, a team of researchers from Japan performed longitudinal analysis on the cellular composition of receptor-binding domain (RBD) memory B cell subsets and its antibody binding and neutralizing activity against the Beta, Delta, and Omicron variants following the second dose of a messenger ribonucleic acid (mRNA) vaccine.

8 Feb 2022

Genetically informed brain atlases help identify hundreds of genomic loci

An international team of scientists has used atlases of the human brain informed by genetics to identify hundreds of genomic loci. Loci is plural for locus, and in genetics indicates the physical location of a gene or variant on a chromosome.

7 Feb 2022

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

In a recent research paper published in the journal Infection, the scientists estimated the transmission and disease severity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant and the effectiveness of the current coronavirus disease 2019 (COVID-19) vaccines against the same by conducting a literature review. Further, a meta-analysis was conducted to obtain a numeric estimate of the vaccine effectiveness against the Delta variant.

7 Feb 2022

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Pregnant individuals infected with SARS-CoV-2, the virus that causes COVID-19, are about 40% more likely to develop serious complications or die during pregnancy than those who aren’t infected with the virus, according to a nationwide study led by a University of Utah Health obstetrician.

7 Feb 2022

Research explores public reactions to COVID-19 pandemic across diverse ethnic groups

Researchers evaluate the attitudes of diverse ethnic groups in the United Kingdom towards the COVID-19 pandemic.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Omicron sequences containing Delta mutation detected during SARS-CoV-2 genomic surveillance

This research letter published in Emerging Infectious Diseases warns scientists to interpret unusual mutations with caution.

7 Feb 2022

COVID-19 patients are at high risk of developing heart problems up to a year after infection

An analysis of federal health data indicates that people who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

7 Feb 2022

Study investigates if prior SARS-CoV-2 infection increases sensitivity to toxin that induces parkinsonism

A recent study explored whether individuals who have recovered from mild to moderate or severe COVID-19 may have an increased risk for developing Parkinson’s disease in the future.

7 Feb 2022

Switching from metered-dose inhaler to a dry powder reduces carbon footprint of asthma treatment

Switching from a metered-dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a pharma industry sponsored study published online in the journal Thorax.

6 Feb 2022

Study examines community and individual risk factors that relate to higher risk of COVID-19

Black residents of Baton Rouge and New Orleans faced twice the risk of SARS-CoV-2 infection as white residents, a study shows.

6 Feb 2022

Many COVID-19 patients still contagious after five days

A new study shows that a high proportion of individuals still test positive for SARS-CoV-2 infection using RATs after five days of quarantine.

6 Feb 2022

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored by researchers from Harvard T.H. Chan School of Public Health.

4 Feb 2022

Most online prostate cancer content lacks Black and Latinx representation, study reports

Despite their higher risks of advanced prostate cancer, Black and Latinx men are under-represented on websites and in online videos providing information and education regarding prostate cancer, reports a study in The Journal of Urology, an official journal of the American Urological Association.

4 Feb 2022

ESMO reiterates commitment to support "Close the care gap" campaign on World Cancer Day

ESMO, the leading professional organization for medical oncology, is joining the global community on the occasion of this year's World Cancer Day (WCD) to reiterate its strong commitment to supporting the "Close the care gap" campaign and securing greater access to care for all cancer patients, regardless of where they live, their financial situation or their lifestyle choices.

4 Feb 2022

Healthcare News and Research

Latest Healthcare News and Research

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

Genetically informed brain atlases help identify hundreds of genomic loci

SARS-CoV-2 Delta variant's effect on COVID-19 vaccine efficacy

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Research explores public reactions to COVID-19 pandemic across diverse ethnic groups

Colchicine holds promise to reduce the risk of severe COVID-19

Omicron sequences containing Delta mutation detected during SARS-CoV-2 genomic surveillance

COVID-19 patients are at high risk of developing heart problems up to a year after infection

Study investigates if prior SARS-CoV-2 infection increases sensitivity to toxin that induces parkinsonism

Switching from metered-dose inhaler to a dry powder reduces carbon footprint of asthma treatment

Study examines community and individual risk factors that relate to higher risk of COVID-19

Many COVID-19 patients still contagious after five days

Older people at highest risk of death are least likely to receive effective COVID-19 treatment

Most online prostate cancer content lacks Black and Latinx representation, study reports

ESMO reiterates commitment to support "Close the care gap" campaign on World Cancer Day

Government announces two significant independent reviews to tackle health disparities

Study evaluates the potential benefits of mass dipstick screening to detect hematuria

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

Review confirms reduced severity of SARS-CoV-2 Omicron infection

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in